Publications by authors named "Iris To"

Claim this Profile
M
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.
Lihua E Budde, Huilai Zhang, Won-Seog Kim, Dai Maruyama, Eduardo M Rego, Laura Maria Fogliatto, Hideki Goto, Iris To, Antonia Kwan

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Laurie H Sehn, Nancy L Bartlett, Matthew J Matasar, Stephen J Schuster, Sarit E Assouline, Loretta J Nastoupil, Iris To, Antonia Kwan, Christopher R Bolen

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative parameters (signalment, digital radiography, urinalysis, urine microbiological culture) and novel algorithm improve prediction of canine urocystolith composition.
Iris To, Allyson C Berent, Chick W Weisse, Anjile An, Brett Harling, Antonia A DeJesus

J Am Vet Med Assoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial.
Matthew Matasar, Nancy L Bartlett, Mazyar Shadman, Lihua E Budde, Ian Flinn, Iris To, Antonia Kwan

Clin Lymphoma Myeloma Leuk· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.
Lihua E Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach, Iris To

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma.
Nancy L Bartlett, Sarit Assouline, Pratyush Giri, Stephen J Schuster, Chan Y Cheah, Anna Johnston, Iris To, Antonia Kwan

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suspected primary pure red cell aplasia in a 4-month-old intact male mixed breed Bernese mountain dog.
Iris To, Patrick R Boelsterli, Julie J Walter, Bronwyn E Rutland

Can Vet J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis